of the Max - MDC
of the Max - MDC
of the Max - MDC
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
What are <strong>the</strong> physiological features <strong>of</strong> microglial<br />
cells in brain tissue?<br />
Microglial cells are <strong>the</strong> pathologic sensors and represent <strong>the</strong><br />
immune cells <strong>of</strong> <strong>the</strong> central nervous system. During any kind<br />
<strong>of</strong> disease or any pathological event such as after trauma,<br />
stroke or in multiple sclerosis, <strong>the</strong> resting microglial cell<br />
transforms into an activated form characterized by an ameboid<br />
morphology. Activated microglia can proliferate,<br />
migrate to <strong>the</strong> site <strong>of</strong> injury, phagocytose, and release a<br />
variety <strong>of</strong> factors like cytokines, chemokines, nitric oxide<br />
and growth factors. They also express a variety <strong>of</strong> receptors<br />
for chemokines and cytokines as expected from a<br />
macrophage-like cell. We have addressed <strong>the</strong> question as to<br />
whe<strong>the</strong>r microglia would also express receptors to sense<br />
neuronal activity. We have recently developed an in situ<br />
model which allows us to study <strong>the</strong> physiological responses<br />
<strong>of</strong> resting and activated microglia. This enables us to characterize<br />
<strong>the</strong> functional receptors and <strong>the</strong> physiological phenotype<br />
<strong>of</strong> microglia in situ. Using this approach, we could<br />
identify microglial receptors for GABA, <strong>the</strong> major inhibitory<br />
transmitter <strong>of</strong> <strong>the</strong> CNS. Activation <strong>of</strong> <strong>the</strong> GABA B receptors<br />
suppressed indicators <strong>of</strong> microglial activation such as <strong>the</strong><br />
release <strong>of</strong> IL-6. A similar reduction in proinflammatory<br />
mediators was found with activation <strong>of</strong> purinergic receptors<br />
and <strong>of</strong> adrenergic receptors.<br />
Microglia expresses a variety <strong>of</strong> purinergic receptors and <strong>the</strong><br />
expression pattern undergoes changes during development<br />
and in pathology. We have found an interesting interplay<br />
between purinergic and adenosine receptors to control<br />
microglial migration. In <strong>the</strong> extracellular space, ATP is rapidly<br />
degraded to ADP, AMP and adenosine. In <strong>the</strong> brain, two<br />
prominent ectonucleotidases, cd39 (NTPDase1) degrading<br />
ATP to AMP and cd73 (5`-nucleotidase) degrading AMP into<br />
adenosine, are exclusively expressed by microglial cells and<br />
even have served as microglial-specific markers. We found<br />
that ATP fails to migration in microglia deficient for cd39.<br />
Function and Dysfunction <strong>of</strong> <strong>the</strong> Nervous System 161